These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19659923)

  • 21. Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
    Hayley S; Crocker SJ; Smith PD; Shree T; Jackson-Lewis V; Przedborski S; Mount M; Slack R; Anisman H; Park DS
    J Neurosci; 2004 Feb; 24(8):2045-53. PubMed ID: 14985447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice.
    Rommelfanger KS; Edwards GL; Freeman KG; Liles LC; Miller GW; Weinshenker D
    Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13804-9. PubMed ID: 17702867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
    Kupsch A; Sautter J; Götz ME; Breithaupt W; Schwarz J; Youdim MB; Riederer P; Gerlach M; Oertel WH
    J Neural Transm (Vienna); 2001; 108(8-9):985-1009. PubMed ID: 11716151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced noradrenaline, but not dopamine and serotonin in motor thalamus of the MPTP primate: relation to severity of parkinsonism.
    Pifl C; Hornykiewicz O; Blesa J; Adánez R; Cavada C; Obeso JA
    J Neurochem; 2013 Jun; 125(5):657-62. PubMed ID: 23331162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late onset loss of hippocampal 5-HT and NE is accompanied by increases in BDNF protein expression in mice co-expressing mutant APP and PS1.
    Szapacs ME; Numis AL; Andrews AM
    Neurobiol Dis; 2004 Aug; 16(3):572-80. PubMed ID: 15262269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxicity of MPTP on neurotransmission in three mouse models of Parkinson's disease.
    Pain S; Gochard A; Bodard S; Gulhan Z; Prunier-Aesch C; Chalon S
    Exp Toxicol Pathol; 2013 Jul; 65(5):689-94. PubMed ID: 23083629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of serotonergic, corticostriatal and kainic acid lesions on the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in mice.
    Melamed E; Pikarski E; Goldberg A; Rosenthal J; Uzzan A; Conforti N
    Brain Res; 1986 Dec; 399(1):178-80. PubMed ID: 3492237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistent depletion of striatal dopamine in mice by m-hydroxy-MPTP.
    Fuller RW; Hemrick-Luecke SK
    Res Commun Chem Pathol Pharmacol; 1986 Aug; 53(2):167-72. PubMed ID: 3764080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The intracortical distribution of norepinephrine, dopamine and serotonin in the cerebral cortex of the cat.
    Reader TA; Masse P; de Champlain J
    Brain Res; 1979 Nov; 177(3):499-513. PubMed ID: 497848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistent depletion of striatal dopamine and cortical norepinephrine in mice by 1-methyl-4-phenyl-1,2,3,6-tetrahydro-3-pyridinol (MPTP-3-OL), an analog of MPTP.
    Hemrick-Luecke SK; Robertson DW; Krushinski JH; Fuller RW
    Life Sci; 1992; 50(8):573-82. PubMed ID: 1736028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A mouse model of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced parkinsonism: effect of norepinephrine terminal destruction].
    Nishi K; Kondo T; Narabayashi H
    No To Shinkei; 1987 Jul; 39(7):663-72. PubMed ID: 3314916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of MPTP on Serotonergic Neuronal Systems and Mitochondrial Complex I Activity in the Living Brain: A PET Study on Conscious Rhesus Monkeys.
    Kanazawa M; Ohba H; Nishiyama S; Kakiuchi T; Tsukada H
    J Nucl Med; 2017 Jul; 58(7):1111-1116. PubMed ID: 28280215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attenuation of MPTP-induced dopaminergic neurotoxicity by TV3326, a cholinesterase-monoamine oxidase inhibitor.
    Sagi Y; Weinstock M; Youdim MB
    J Neurochem; 2003 Jul; 86(2):290-7. PubMed ID: 12871570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment.
    Petroske E; Meredith GE; Callen S; Totterdell S; Lau YS
    Neuroscience; 2001; 106(3):589-601. PubMed ID: 11591459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Somatostatin content increases following norepinephrine depletion in frontal cortex of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.
    Mitsuo K; Schwartz JP
    J Neurochem; 1992 Jul; 59(1):267-72. PubMed ID: 1351925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebral metabolic pattern associated with progressive parkinsonism in non-human primates reveals early cortical hypometabolism.
    Molinet-Dronda F; Blesa J; Del Rey NL; Juri C; Collantes M; Pineda-Pardo JA; Trigo-Damas I; Iglesias E; Hernández LF; Rodríguez-Rojas R; Gago B; Ecay M; Prieto E; García-Cabezas MÁ; Cavada C; Rodríguez-Oroz MC; Peñuelas I; Obeso JA
    Neurobiol Dis; 2022 Jun; 167():105669. PubMed ID: 35219857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MPTP-induced executive dysfunction is associated with altered prefrontal serotonergic function.
    Maiti P; Gregg LC; McDonald MP
    Behav Brain Res; 2016 Feb; 298(Pt B):192-201. PubMed ID: 26393431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The serotonin and norepinephrine innervation of primary visual cortex in the cynomolgus monkey (Macaca fascicularis).
    Kosofsky BE; Molliver ME; Morrison JH; Foote SL
    J Comp Neurol; 1984 Dec; 230(2):168-78. PubMed ID: 6096418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Noradrenaline depletion exacerbates MPTP-induced striatal dopamine loss in mice.
    Marien M; Briley M; Colpaert F
    Eur J Pharmacol; 1993 Jun; 236(3):487-9. PubMed ID: 7689466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) reduces dopamine and serotonin but accelerates norepinephrine metabolism in the rat brain. Effect of chronic pretreatment with MPTP.
    Enz A; Hefti F; Frick W
    Eur J Pharmacol; 1984 May; 101(1-2):37-44. PubMed ID: 6086364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.